Skip to content

A prospective cohort study of endovascular therapy for acute occlusion of major intracranial and extracranial arteries

A prospective cohort study of endovascular therapy for acute occlusion of major intracranial and extracranial arteries

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124865
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age = 18 years with no upper age limit. 2.Clinically diagnosed or imaging-confirmed acute ischemic stroke. 3.Acute occlusion of a large or major intracranial artery confirmed by DSA, CTA, or MRA. 4.ritten informed consent obtained from the patient or their legally authorized representative/guardian.

Exclusion criteria

Exclusion criteria: 1.Intracranial hemorrhage confirmed by head CT or MRI. 2.Pregnant or breastfeeding women. 3.Pre-existing non-stroke conditions with expected survival <6 months (e.g., advanced cancer, end-stage renal disease, Alzheimer's disease, severe infectious disease, amyotrophic lateral sclerosis). 4.Expectation of inability to complete follow-up. 5.Intracranial space-occupying lesion.

Design outcomes

Primary

MeasureTime frame
Symptomatic intracranial hemorrhage (SICH) within 48 hours;90 days favorable outcomes (%);Proportion of patients with 90-day mRS 0-3;

Secondary

MeasureTime frame
Proportion of patients with 10-year mRS 0-3;Distiburion of 5-year mRS Score;Proportion of patients with 5-year mRS 0-3;Distiburion of 5-year mRS Score;Incidence of non-intracranial bleeding complications;Proportion of patients with 1-year mRS 0-2;90-day EQ-5D utility index score;Change in NIHSS score at 5-7 days post-treatment (If the time of discharge is earlier than 5-7 days, it is the time of discharge);Proportion of patients with 3-year mRS 0-3;Proportion of patients with 20-year mRS 0-2;Proportion of patients with 20-year mRS 0-3;Distiburion of 20-year mRS Score;Asymptomatic intracranial hemorrhage within 48 hours;Proportion of patients with 90-day mRS 0-4;Distiburion of 90-day mRS Score;Proportion of patients with 15-year mRS 0-3;Proportion of patients with 15-year mRS 0-2;Distiburion of 1-year mRS Score;All-cause mortality at 90 days;Distiburion of 3-year mRS Score;Proportion of patients with 3-year mRS 0-2;Proportion of patients with 5-year mRS 0-2;Proportion of patients with 10-year mRS 0-2;Proportion of patients with 1-year mRS 0-3;Distiburion of 15-year mRS Score;

Countries

China

Contacts

Public ContactWenjie Zi

The Second Affiliated Hospital of the Army Medical University

ziwenjie@126.com+86 185 2303 3816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026